Vident Advisory’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$608K Sell
12,755
-240
-2% -$11.1K ﹤0.01% 1260
2026
Q1
$569K Buy
12,995
+1,198
+10% +$54.7K ﹤0.01% 1183
2025
Q4
$523K Buy
11,797
+102
+0.9% +$4.39K ﹤0.01% 1144
2025
Q3
$494K Sell
11,695
-1,117
-9% -$45K ﹤0.01% 1207
2025
Q2
$470K Sell
12,812
-1,289
-9% -$47.9K 0.01% 1092
2025
Q1
$537K Sell
14,101
-3,657
-21% -$136K 0.01% 998
2024
Q4
$672K Sell
17,758
-11,518
-39% -$460K 0.01% 816
2024
Q3
$1.19M Buy
29,276
+1,042
+4% +$39.4K 0.03% 567
2024
Q2
$967K Buy
28,234
+249
+0.9% +$7.84K 0.03% 604
2024
Q1
$886K Buy
27,985
+304
+1% +$9.24K 0.02% 618
2023
Q4
$849K Buy
27,681
+119
+0.4% +$3.82K 0.02% 609
2023
Q3
$914K Buy
+27,562
New +$880K 0.03% 543

Other funds holding OHI

Vident Advisory's OHI Position: Q2 2026 in Review

Vident Advisory reduced its Omega Healthcare (OHI) stake by 1.8% in Q2 2026, selling an estimated $11.1K and leaving 12,755 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #1260.

Vident Advisory first reported a position in OHI in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.19M in Q3 2024. 764 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Vident Advisory held 12,755 shares of Omega Healthcare worth $608K as of Q2 2026.
  • Vident Advisory sold 240 Omega Healthcare shares in Q2 2026, an estimated $11.1K.
  • Omega Healthcare made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1260 holding.
  • Vident Advisory first reported a position in Omega Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Vident Advisory's Omega Healthcare position peaked at $1.19M in Q3 2024.
  • 764 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.